Evidence map›Paper›PMID 35361013›Full record

ArticleTumori2023

A molecular reappraisal of matrix-producing breast metaplastic carcinoma highlighted by PLAG1 and MYC rearrangements.

Rebecca Salvatori, Marco Manzoni, Daniela Lepanto, Viviana Stufano, Simona Pessina, Chiara Zanetti, Fabio Bassi, Giovanni Mazzarol, Emilia Montagna, Fausto Maffini

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tumori, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Frontiers in cardiovascular medicine · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Rebecca SalvatoriDepartment of Surgical Pathology, European Institute of Oncology, IRCCS, Milan, Italy.
Marco ManzoniDepartment of Surgical Pathology, European Institute of Oncology, IRCCS, Milan, Italy.
Daniela LepantoDepartment of Surgical Pathology, European Institute of Oncology, IRCCS, Milan, Italy.
Viviana StufanoDepartment of Surgical Pathology, European Institute of Oncology, IRCCS, Milan, Italy.
Simona PessinaDepartment of Surgical Pathology, European Institute of Oncology, IRCCS, Milan, Italy.
Chiara ZanettiDepartment of Surgical Pathology, European Institute of Oncology, IRCCS, Milan, Italy.
Fabio BassiDepartment of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Giovanni MazzarolDepartment of Surgical Pathology, European Institute of Oncology, IRCCS, Milan, Italy.
Emilia MontagnaDepartment of Breast Medical Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Fausto MaffiniDepartment of Surgical Pathology, European Institute of Oncology, IRCCS, Milan, Italy.ORCID 0000-0002-4554-8956
Istituti di Ricovero e Cura a Carattere Scientifico · ITEuropean Institute of Oncology · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVery little is currently known about molecular alteration of matrix-producing carcinoma of the breast. However, the morphological similarity with other neoplasm with a myxo-chondroid component is remarkable. In this pilot study we evaluated the molecular alterations involving

methodsWe evaluated

resultsAmong the 12 cases of matrix producing carcinomas we found that the three cases harboring

conclusionThis is the first report to the best of our knowledge that shows a possible correlation between a matrix producing carcinoma with

Indexed as

Adenoma, PleomorphicCarcinomaSalivary Gland NeoplasmsDNA-Binding ProteinsHumansImmunohistochemistryPilot ProjectsProto-Oncogene Proteins c-mycTranscription FactorsDNA-Binding ProteinsPLAG1 protein, humanProto-Oncogene Proteins c-mycTranscription Factorsbreast tumorMatrix producing metaplastic carcinoma of breastMYC rearrangementPLAG1 rearrangementsalivary gland tumor

Identifiers

PMID35361013
PMCPMC10070549
OpenAlexW4220734582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.